Piper Jaffray Cuts Price Target on H&R Block (HRB) to $28 Following 1Q
- Stocks face worst month since September, yen swings after BoJ
- Microsoft fiscal Q3 results top estimates as AI revolution spurs cloud growth
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
- Oil prices on track to snap two-week losing streak
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Union Pacific beats profit estimates on stronger pricing, resumes share buyback
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hertz Global (HTZ) misses earnings expectations as fleet costs weigh
- Teladoc (TDOC) Misses Q1 EPS by 3c, offers outlook
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Oppenheimer Reiterates Perform on H&R Block (HRB) Following 1Q Report
August 31, 2016 10:03 AM EDTOppenheimer reiterated a Perform rating on H&R Block (NYSE: HRB), following the company's 1Q earnings report. HRB reported EPS of -$0.55, consistent with consensus estimates of -$0.53. Management indicated its cost savings are pacing on track with internal expectations.
Analyst Scott Schneeberger... More
After-Hours Stock Movers 08/30: (VEEV) (GSAT) (NCS) Higher; (AVAV) (MDCO) (HRB) (PANW) Lower (more...)
August 30, 2016 5:44 PM EDTToday's After-Hours Movers
AeroVironment (NASDAQ: AVAV) 13.3% LOWER; reported Q1 EPS of ($0.51), may not compare to the analyst estimate of ($0.17). Revenue for the quarter came in at $36.2 million versus the consensus estimate of $37.81 million.
The Medicines Company (Nasdaq: MDCO) 8% LOWER; provided an update on its clinical dyslipidemia research programs for MDCO-216 (which contains APoA-1 Milano) and PCSK9si (PCSK9 synthesis inhibitor). MDCO-216. A planned, interim analysis of the first 40 randomized patients completing treatment in the MILANO-PILOT... More
H&R Block (HRB) Misses Q1 EPS by 2c
August 30, 2016 4:20 PM EDTH&R Block (NYSE: HRB) reported Q1 EPS of ($0.55), $0.02 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $125 million versus the consensus estimate of $132.62 million.
"Because of the highly seasonal nature of our business, the fiscal first... More
H&R Block (HRB) September option volume and volatility increases into Q2 and outlook
August 30, 2016 2:32 PM EDTH&R Block (NYSE: HRB) September 26 calls and September 24 puts are active on total call volume of 990 contracts (940 puts) into the expected release of Q2 results today after the market close. September call option implied volatility is at 45, October is at 31; compared to its 52-week range of 30 to 84.
... More